The ventricular conduction system (VCS) is critically important for normal myocardial excitation and contraction. Heritable and acquired syndromes perturbing VCS formation or function are responsible for a substantial burden of cardiovascular disease, including heart block, triggered and reentrant arrhythmias, sudden cardiac death, as well as myocardial dyssynchrony and progression of heart failure. Using genetically encoded conduction system reporter mice, comparative transcriptional profiling, and a battery of functional assays, our laboratory has pioneered studies of VCS development, physiology and disease pathogenesis. Through this approach, we have identified and characterized the transcriptional signature of Purkinje cells and identified a number of novel genes that regulate diverse aspects of VCS biology, including transcription factors, ion channel subunits and regulatory proteins. In the current application, we propose to establish a more global and comprehensive understanding of gene regulatory networks that are operative in this rare population of excitable cells, by extending our analysis to include microRNAs that are differentially expressed in the VCS. More specifically, we propose to: determine the cell autonomous requirements for microRNAs in the VCS; identify microRNAs required for Purkinje cell differentiation using functional genomics screens; and define Purkinje cell transcriptional signatures and electrophysiology in health and disease.

Public Health Relevance

Heart disease is the leading cause of death in the United States and other developed countries and almost half of these deaths occur suddenly from heart rhythm abnormalities. Our research is directed toward understanding the mechanisms responsible for normal and abnormal heart rhythmicity with a particular focus on arrhythmic diseases that arise from abnormalities in the specialized cardiac conduction system. This project focuses on studies of transcriptional regulation of the specialized cardiac conduction system during development, normal physiology and in disease states.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL146107-03
Application #
10063955
Study Section
Electrical Signaling, Ion Transport, and Arrhythmias Study Section (ESTA)
Program Officer
Balijepalli, Ravi C
Project Start
2019-01-01
Project End
2022-11-30
Budget Start
2020-12-01
Budget End
2021-11-30
Support Year
3
Fiscal Year
2021
Total Cost
Indirect Cost
Name
New York University
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
121911077
City
New York
State
NY
Country
United States
Zip Code
10016